Chugai Pharmaceutical Co (MEX:4519N) E10: MXN18.38 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4519N Chugai Pharmaceutical Co Ltd MEX:4519N
97 GF Score
Price MXN825.61
GF Value MXN873.09
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co E10?

Chugai Pharmaceutical Co MEX:4519N 97 E10 is MXN18.38 as of Mar. 2026. GuruFocus rates MEX:4519N with a GF Score™ of 97/100 and a GF Value™ of MXN873.09. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN7.970. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN18.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Chugai Pharmaceutical Co's average E10 Growth Rate was 18.20% per year. During the past 3 years, the average E10 Growth Rate was 20.60% per year. During the past 5 years, the average E10 Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Chugai Pharmaceutical Co was 29.80% per year. The lowest was 16.20% per year. And the median was 24.95% per year.

As of today (2026-07-21), Chugai Pharmaceutical Co's current stock price is MXN825.61. Chugai Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was MXN18.38. Chugai Pharmaceutical Co's Shiller PE Ratio of today is 44.92.

During the past 13 years, the highest Shiller PE Ratio of Chugai Pharmaceutical Co was 132.28. The lowest was 34.06. And the median was 55.82.


Chugai Pharmaceutical Co  (MEX:4519N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Chugai Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=825.61/18.38
=44.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Chugai Pharmaceutical Co was 132.28. The lowest was 34.06. And the median was 55.82.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Chugai Pharmaceutical Co E10 Related Terms


Chugai Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Chugai Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co E10 Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 15.28 11.64 16.11 15.15

Chugai Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.60 18.76 18.37 15.15 18.38

MEX:4519N vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Shiller PE Ratio falls into.


MEX:4519N
97GF Score
Chugai Pharmaceutical Co Ltd MEX:4519N
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chugai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.97/112.7000*112.7000
=7.970

Current CPI (Mar. 2026) = 112.7000.

Chugai Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 1.824 98.100 2.095
201609 1.335 98.000 1.535
201612 1.138 98.400 1.303
201703 1.879 98.100 2.159
201706 1.747 98.500 1.999
201709 2.104 98.800 2.400
201712 1.642 99.400 1.862
201803 2.907 99.200 3.303
201806 2.258 99.200 2.565
201809 2.199 99.900 2.481
201812 2.357 99.700 2.664
201903 3.718 99.700 4.203
201906 3.699 99.800 4.177
201909 5.373 100.100 6.049
201912 4.221 100.500 4.733
202003 6.823 100.300 7.667
202006 6.619 99.900 7.467
202009 7.647 99.900 8.627
202012 6.092 99.300 6.914
202103 5.420 99.900 6.114
202106 7.772 99.500 8.803
202109 9.758 100.100 10.986
202112 10.827 100.100 12.190
202203 13.448 101.100 14.991
202206 6.606 101.800 7.313
202209 5.784 103.100 6.323
202212 9.000 104.100 9.744
202303 6.024 104.400 6.503
202306 6.132 105.200 6.569
202309 5.554 106.200 5.894
202312 6.535 106.800 6.896
202403 5.008 107.200 5.265
202406 7.888 108.200 8.216
202409 9.164 108.900 9.484
202412 7.544 110.700 7.680
202503 8.109 111.100 8.226
202506 7.694 111.700 7.763
202509 8.384 112.000 8.436
202512 9.010 113.000 8.986
202603 7.970 112.700 7.970

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN18.38 mean?
Chugai Pharmaceutical Co (MEX:4519N) has a E10 of MXN18.38 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors.
Is Chugai Pharmaceutical Co's E10 too high?
Chugai Pharmaceutical Co's current E10 is MXN18.38. Overall, Chugai Pharmaceutical Co has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's E10 compare to LLY and JNJ?
Chugai Pharmaceutical Co's E10 of MXN18.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors. Chugai Pharmaceutical Co's current E10 is MXN18.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Chugai Pharmaceutical Co (MEX:4519N) has a current E10 of MXN18.38. The stock's GF Value™ is MXN873.09, compared to a current price of MXN825.61 — trading 5.4% below its estimated fair value. The current E10 is MXN18.38. Chugai Pharmaceutical Co's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Chugai Pharmaceutical Co (MEX:4519N), the current E10 is MXN18.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (MEX:4519N) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN825.61 is trading 5.4% below its estimated GF Value™ of MXN873.09.

Key valuation signals for MEX:4519N:

  • E10: MXN18.38
  • GF Value™: MXN873.09 vs. price of MXN825.61 (5.4% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the MEX:4519N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
97GF Score

Get the complete analysis for MEX:4519N

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN825.61
Price
MXN873.09
GF Value